T reatment of moderate-to-severe Crohn's disease should prioritize early use of higher-efficacy advanced therapies rather ...

The American Gastroenterological Association (AGA) has released a comprehensively updated clinical guideline on the ...

The (AGA) has released a comprehensively updated clinical guideline on the pharmacological management of moderate-to-severe Crohn's disease.

The American Gastroenterological Association has released updated guidelines for treating moderate-to-severe Crohn’s disease, outlining 16 evidence-based recommendations that prioritize advanced ...

Find out about the early symptoms of Crohn’s disease, to detect it sooner and manage it better. Learn to pay attention to ...

Artificial intelligence helps UCSD scientists discover a biological process connected to the bowel disease, potentially ...

Oxford researchers discover rogue fibroblasts that erode tissue and stabilize tunnels in Crohn’s fistulas, revealing targets ...

STENOVA trial achieves primary endpoint in 103 study participants after 12 weeks of treatment -- -- Pharmacokinetic results confirm ...

Add articles to your saved list and come back to them any time. NeuroScientific Biopharmaceuticals has medicated a fourth fistulising Crohn’s disease patient with its unique “StemSmart” stem-cell ...

Proactive care and early treatment help prevent serious IBD complications and improve patients’ quality of life.